Y-Intercept (HK)’s Xenon Pharmaceuticals XENE Stock Holding History

Y-Intercept (HK)’s Portfolio XENE Stock Details XENE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-85,388	Closed	-$4.97M	–	2231
2026 Q1	$4.97M	Buy	85,388 +12,431	+17%	+$573K	0.09%	321
2025 Q4	$3.27M	Buy	+72,957	New	+$3.06M	0.07%	388
2025 Q2	–	Sell	-11,949	Closed	-$401K	–	2071
2025 Q1	$401K	Buy	+11,949	New	+$454K	0.03%	796
2024 Q4	–	Sell	-24,557	Closed	-$967K	–	1722
2024 Q3	$967K	Buy	24,557 +10,007	+69%	+$403K	0.06%	459
2024 Q2	$567K	Sell	14,550 -3,755	-21%	-$150K	0.03%	758
2024 Q1	$788K	Buy	+18,305	New	+$842K	0.06%	488
2022 Q3	–	Sell	-7,324	Closed	-$223K	–	1318
2022 Q2	$223K	Buy	+7,324	New	+$222K	0.03%	653

Other funds holding XENE

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Elmwood Wealth Management Berkeley, California $400M AUM 17.81% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

FNY Investment Advisers New York $277M AUM 98.95% 1-Year Est. Return

Harbor Investment Advisory Lutherville, Maryland $1.43B AUM 30.71% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return